share_log

北陆药业(300016.SZ):续签一致行动协议书

Beijing Beilu Pharmaceutical (300016.SZ): Renewed the concerted action agreement.

Gelonghui Finance ·  Dec 16, 2024 16:52

On December 16, Ge Long Hui reported that Beijing Beilu Pharmaceutical (300016.SZ) announced that the company recently renewed the "Consistent Action Agreement" with Ms. Zeng Chunhui, the second-largest Shareholder of Haichang Pharmaceutical. This renewal of the "Consistent Action Agreement" did not lead to any changes in the actual control of Haichang Pharmaceutical, and the controlling Shareholder of Haichang Pharmaceutical remains the company. This renewal of the "Consistent Action Agreement" is beneficial for the company to maintain the stability of the actual control of its holding subsidiary, Haichang Pharmaceutical, ensuring consistency in major decision-making at Haichang Pharmaceutical, which is beneficial for the company's development strategy and the coherence and stability of its Operation management. It will not have any adverse effects on the daily Operation management of the company and Haichang Pharmaceutical, and there is no situation that damages the interests of small and medium-sized investors.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment